This event is archived. Final snapshot from when the story concluded. View on Dashboard
Events / Technology / India Eye Infection Drug Resistance Study
Tech medical study

India Eye Infection Drug Resistance Study

Analysis based on 8 articles · First reported Apr 07, 2026 · Last updated Apr 08, 2026

Sentiment
-60
Attention
4
Articles
8
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard
Market Impact

The study's findings on widespread antimicrobial resistance in India could negatively impact pharmaceutical companies developing antibiotics, as existing treatments become less effective. It also signals a potential increase in healthcare costs due to more complex and prolonged treatments for eye infections, affecting the healthcare sector.

Pharmaceuticals Healthcare
Event Summary

A collaborative study by CSIR-Centre for Cellular and Molecular Biology and L.V. Prasad Eye Institute in India has revealed alarming levels of antimicrobial resistance (AMR) in bacteria causing eye infections. Over 45% of bacterial isolates from patient samples were found to be multidrug-resistant, including vancomycin-resistant Staphylococcus aureus and extensively drug-resistant Klebsiella pneumoniae. The study, co-led by Karthik Bharadwaj, Divya Tej Sowpati, and Joveeta Joseph, highlighted widespread resistance to commonly used antibiotics like fluoroquinolones, challenging the reliance on empirical therapy. Experts, including Vinay K. Nandicoori and Prashant Garg, emphasized the urgent need for microbiology-guided diagnosis, targeted treatment approaches, and strengthened antimicrobial stewardship to curb the growing threat of AMR, which reflects a broader environmental issue.

Entities Involved
ngo
L.V. Prasad Eye Institute
L.V. Prasad Eye Institute contributed clinical expertise, patient samples, and microbiological characterization to the study, highlighting the need for microbiology-guided diagnosis.
Importance 90.0 Sentiment 20.0
per
Karthik Bharadwaj
Karthik Bharadwaj, a clinician-scientist at CSIR-Centre for Cellular and Molecular Biology, co-led the study and expressed concern over the spread of resistant strains and AMR genes.
Importance 70.0 Sentiment 10.0
per
Joveeta Joseph
Joveeta Joseph, Head of Microbiology at L.V. Prasad Eye Institute, co-led the study and emphasized the need for region-specific treatment guidelines and antimicrobial stewardship in ophthalmology.
Importance 70.0 Sentiment 10.0
per
Divya Tej Sowpati
Divya Tej Sowpati from CSIR-Centre for Cellular and Molecular Biology co-led the study on antimicrobial resistance in eye infections.
Importance 60.0 Sentiment 10.0
per
Vinay K. Nandicoori
Vinay K. Nandicoori, Director of CSIR-Centre for Cellular and Molecular Biology, highlighted the importance of collaboration between clinicians and scientists to address antimicrobial resistance.
Importance 50.0 Sentiment 10.0
per
Prashant Garg
Prashant Garg, Executive Chair of L.V. Prasad Eye Institute, stated that eye infections reflect the broader antimicrobial resistance landscape, positioning the eye as a valuable site for surveillance.
Importance 50.0 Sentiment 10.0
cnt
India
Importance 0.0 Sentiment 0.0
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.